Abdel-Rahman, OmarCheung, Winson Y.2018-09-262018-09-262018-06-21Omar Abdel-Rahman and Winson Y. Cheung, “Integrating Systemic Therapies into the Multimodality Treatment of Resectable Colorectal Liver Metastases,” Gastroenterology Research and Practice, vol. 2018, Article ID 4326082, 4 pages, 2018. doi:10.1155/2018/4326082http://dx.doi.org/10.1155/2018/4326082http://hdl.handle.net/1880/107815Colorectal carcinoma (CRC) is one of the most common cancers worldwide. A considerable proportion of CRC patients may present with metastatic disease either at upfront presentation (synchronous with the primary) or following diagnosis and treatment of the primary tumor (metachronous). Management of CRC liver metastases is a challenging endeavor which frequently necessitates proper assessment of patient- and disease-related factors. There is an opportunity within the management of CRC liver metastases to incorporate multiple treatment modalities (including surgery, other locoregional treatments, and systemic therapy). The current review aims to provide an updated overview on the optimal management strategy for CRC patients with liver metastases with a specific focus on the integration of systemic and/or locoregional treatments among patients with resectable or potentially resectable disease.Journal Article2018-09-26enCopyright © 2018 Omar Abdel-Rahman and Winson Y. Cheung. This is an open access article distributed under the Creative Commons Attribution License, which permits unrestricted use, distribution, and reproduction in any medium, provided the original work is properly cited.10.11575/PRISM/32978